文献速递痛风与晶体性关节病

新西兰毛利与太平洋人群的线粒体遗传变异与痛风

Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.
PubMed 文献 · Ann Rheum Dis · 2017-12-15

研究对毛利与太平洋人群的线粒体全基因组进行测序,并分析线粒体DNA拷贝数变异,发现B单倍群高变区I异质性位点16181与痛风风险升高相关,而线粒体DNA拷贝数增加对痛风风险具有保护作用。

要点

  • 线粒体DNA拷贝数增加与痛风风险降低相关,且在三个独立样本中结果一致
  • 高变区I位点16181异质性与痛风风险升高相关(OR=1.57,P=0.001)
  • 线粒体DNA拷贝数增加同时与痛风发作频率升高相关

核心结论

  • 线粒体DNA拷贝数减少与高尿酸血症人群痛风风险的关联在三个波利尼西亚样本集中得到重复验证。
  • 数据与新兴研究一致,提示线粒体对NLRP3和ASC炎症小体亚基的共定位具有重要作用,而该过程对痛风中间质素-1β的生成至关重要。

研究设计与样本

  • 研究对来自新西兰的437例毛利与太平洋人群(主要为男性)进行线粒体全基因组测序,其中痛风327例、无痛风110例。
  • 线粒体DNA拷贝数变异通过全基因组测序数据(32例病例、43例对照)和尿酸盐基因座靶向重测序数据(151例病例、222例对照)评估相对读取深度确定。
  • 采用定量PCR在扩展样本集1159例毛利与太平洋男女(612例病例、547例对照)中复制拷贝数发现。

主要发现

  • 测序样本中线粒体遗传多样性相对较低,约96%属于B4a1a及其衍生亚支。
  • 高变区I的B单倍群异质性与痛风风险升高相关(位置16181:OR=1.57,P=0.001)。
  • 线粒体DNA拷贝数增加对痛风风险具有保护作用,使用高尿酸血症对照时在三个独立样本集中效应一致(OR=0.89,P=0.007;OR=0.90,P=0.002;OR=0.76,P=0.03)。
  • 在用于拷贝数分析的两个较大样本集中,线粒体DNA增加同时与痛风患者痛风发作频率升高相关(β=0.003,P=7.1×10-7;β=0.08,P=1.2×10-4)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mitochondria have an important role in the induction of the NLRP3 inflammasome response central in gout. The objective was to test whether mitochondrial genetic variation and copy number in New Zealand Māori and Pacific (Polynesian) people in Aotearoa New Zealand associate with susceptibility to gout. METHODS: 437 whole mitochondrial genomes from Māori and Pacific people (predominantly men) from Aotearoa New Zealand (327 people with gout, 110 without gout) were sequenced. Mitochondrial DNA copy number variation was determined by assessing relative read depth using data produced from whole genome sequencing (32 cases, 43 controls) and targeted resequencing of urate loci (151 cases, 222 controls). Quantitative PCR was undertaken for replication of copy number findings in an extended sample set of 1159 Māori and Pacific men and women (612 cases, 547 controls). RESULTS: There was relatively little mitochondrial genetic diversity, with around 96% of those sequenced in this study belonging to the B4a1a and derived sublineages. A B haplogroup heteroplasmy in hypervariable region I was found to associate with a higher risk of gout among the mitochondrial sequenced sample set (position 16181: OR=1.57, P=0.001). Increased copies of mitochondrial DNA were found to protect against gout risk with the effect being consistent when using hyperuricaemic controls across each of the three independent sample sets (OR=0.89, P=0.007; OR=0.90, P=0.002; OR=0.76, P=0.03). Paradoxically, an increase of mitochondrial DNA also associated with an increase in gout flare frequency in people with gout in the two larger sample sets used for the copy number analysis (β=0.003, P=7.1×10-7; β=0.08, P=1.2×10-4). CONCLUSION: Association of reduced copy number with gout in hyperuricaemia was replicated over three Polynesian sample sets. Our data are consistent with emerging research showing that mitochondria are important for the colocalisation of the NLRP3 and ASC inflammasome subunits, a process essential for the generation of interleukin-1β in gout.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Gosling AL, Boocock J, Dalbeth N, et al. Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand. Ann Rheum Dis. 2017. PMID: 29247128. doi:10.1136/annrheumdis-2017-212416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。